sade082

Considering the design of the inhaler has not changed since it was invented in 1957 , we are long overdue for a revolutionary breakthrough. Say hello to Bloom, an inhaler the size of a credit card that can easily fit into a wallet. Traditional inhalers are nice in that they are small, lightweight, easily portable. Yet they are still bulky, and -- let's face it -- they are easy to forget. How about an inhaler that is always with you, snug nice and secure inside your wallet. When you need it all you do is open your wallet and there it will be.  Now, the idea here is you purchase a regular inhaler. You take out the cannister and insert it into the top of the Bloom inhaler. You then squirt it six times. Bloom saves the medicine without wasting any of it. Now you place Bloom inside your wallet for safe keeping. Six puffs will be available whenever you need them. No need to worry about forgetting your inhaler. No need for stuffing that bulky inhaler inside your pocket.  The product ...

The follow ing was originally published at healthcentral.com/copd on May 20, 2015 Inhaler -vs- nebulizer: which one is best for COPD One of the best ways of controlling COPD is by inhaling COPD medicine. To do this, some use an inhaler with a spacer, some use a nebulizer, and some use both. So which one is the best way to deliver COPD medicine to your lungs? To learn about inhalers, check out my post “ What is an inhaler ?” To learn about nebulizers, check out my post “ What is a nebulizer ?” Both inhalers and nebulizers allow patients to inhale a low dose of a medicine to receive a more rapid response (sometimes immediate), with fewer side effects than taking the medicine systemically. So they both work great for people with lung disease. That said, let’s delve into this subject a little deeper and compare the two. Medicine Distribution . Many studies have been done comparing inhalers with nebulizers. Most suggest that, when used properly, inhalers used with a spacer work equal...

Some of my asthmatic friends constantly criticize pharmaceuticals as run by a bunch of evil rich people who are greedy and make money at the expense of the sick.  Their evidence is the fact that newer, non-patented, asthma medicine costs so much.  I would like to argue that pharmaceutical companies (or most of them) are run by people who simply want to make enough profit to stay in business. It is true that asthma medicine costs too much. Consider that if your doctor prescribes Advair to control your asthma, it will cost you about $250 a month if you pay out of pocket.  If you have a copay the cost will be about $70 per month.  This copay is high, considering a typical copay for generic medicine is between $20 and $40 a month.  Consider the following facts as reported by medicine.net, " Drugs: Why they cost so much? " The high price of Advair is not the result of greed, but of regulation. In fact, pharmaceuticals are constantly looking to find new medicines to h...